Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 82051-82100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06206681
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
N/ARecruiting
1,000 participants
Started: Nov 1, 2022 · Completed: Sep 1, 2025
4 conditions1 sponsor1 location
NCT05573113
Comparative Effectiveness Trial for Diagnosis of Necrotizing Enterocolitis
NAActive, not recruiting
182 participants
Started: Nov 1, 2022 · Completed: Aug 30, 2025
1 condition3 sponsors2 locations
NCT05518513
Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty
NARecruiting
66 participants
Started: Nov 1, 2022 · Completed: Sep 30, 2024
2 conditions1 sponsor1 location
NCT06125262
Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.
N/ARecruiting
100 participants
Started: Nov 1, 2022 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT05610332
Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes
PHASE3Not yet recruiting
216 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2027
1 condition1 sponsor2 locations
NCT05876130
Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer
NARecruiting
92 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2031
1 condition1 sponsor1 location
NCT05550558
Camrelizumab Plus Anlotinib in Patients With Recurrent Sporadic MMRd Endometrial Cancer
PHASE2Not yet recruiting
43 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor0 locations
NCT05403138
Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
PHASE2/PHASE3Active, not recruiting
135 participants
Started: Nov 1, 2022 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT05593679
A Multi-center Cardiac PYP Scan Registry in Taiwan
N/ARecruiting
1,000 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT04947189
Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer
PHASE1/PHASE2Recruiting
65 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06037993
Endocannabinoid Activity Remodulation for Psychosis Liability in Youth
NARecruiting
20 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2025
3 conditions2 sponsors2 locations
NCT05583175
Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies
PHASE2Recruiting
50 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2024
4 conditions1 sponsor1 location
NCT05750901
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
NARecruiting
1,000 participants
Started: Nov 1, 2022 · Completed: Jun 20, 2026
1 condition1 sponsor1 location
NCT05575271
Implantable Vagus Nerve Stimulation Modulation of Coeruleus-Norepinephrine Network for Mild-Moderate AD Patients
NANot yet recruiting
6 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05363280
Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC
PHASE2Active, not recruiting
36 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor6 locations
NCT04564482
PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer
NARecruiting
20 participants
Started: Nov 1, 2022 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT05553197
Intersession Processes in Psychotherapeutic Treatments Using an Ecological Momentary Assessment Approach (ISA-Bell)
NARecruiting
84 participants
Started: Nov 1, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05180097
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
PHASE2Recruiting
84 participants
Started: Nov 1, 2022 · Completed: Jun 30, 2026
1 condition4 sponsors18 locations
NCT07181070
The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor
N/ARecruiting
70 participants
Started: Nov 1, 2022 · Completed: Oct 31, 2026
4 conditions1 sponsor1 location
NCT05473910
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation
PHASE1Recruiting
75 participants
Started: Nov 1, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor15 locations
NCT05244798
Sintilimab Plus NCT or NCRT Versus NCRT for ESCC
PHASE3Not yet recruiting
420 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
1 condition10 sponsors1 location
NCT05559892
Conditional Cash Transfer Intervention to Improve T2DM
NAActive, not recruiting
100 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05468554
Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer
PHASE3Not yet recruiting
160 participants
Started: Nov 1, 2022 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT05544188
Functional Pathologies of the Musculoskeletal System in Physiotherapy Students
NARecruiting
60 participants
Started: Nov 1, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05909436
Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
PHASE1/PHASE2Recruiting
107 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05415111
The Adjunctive Effect of Soft Tissue Augmentation Procedures of Moderate-severe Peri-implantitis
NARecruiting
120 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor3 locations
NCT05531240
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
NARecruiting
104 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
3 conditions5 sponsors4 locations
NCT05377723
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
NARecruiting
100 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05545358
Neural Bases of Phantom Pain After Amputation
N/ANot yet recruiting
75 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor0 locations
NCT05593419
Selecting Patients Who May Benefit From Immunotherapy by Tissue-based Biomarkers.
N/ARecruiting
300 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT04612907
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
NARecruiting
420 participants
Started: Oct 31, 2022 · Completed: Sep 30, 2032
3 conditions1 sponsor1 location
NCT05781399
First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria
PHASE1/PHASE2Active, not recruiting
135 participants
Started: Oct 31, 2022 · Completed: Dec 15, 2025
1 condition1 sponsor15 locations
NCT05354869
Transvaginal Electrical Stimulation for Myofascial Pelvic Pain
NARecruiting
60 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04927377
Accessible and Inclusive Diabetes Telecoaching Self-Management Program
NARecruiting
90 participants
Started: Oct 31, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05594914
AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
PHASE2Not yet recruiting
47 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05707442
Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)
PHASE3Recruiting
74 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05632588
Near Fatal Asthma in Children and Young People
N/ARecruiting
400 participants
Started: Oct 31, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04020055
A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease
PHASE3Recruiting
14 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations
NCT05558319
NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
PHASE3Not yet recruiting
480 participants
Started: Oct 31, 2022 · Completed: Apr 30, 2029
1 condition5 sponsors68 locations
NCT06826092
Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy
PHASE2Recruiting
110 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05429996
Ultrastructural Collagen Markers in Ehlers Danlos Syndromes
N/AEnrolling by invitation
20 participants
Started: Oct 31, 2022 · Completed: Aug 1, 2024
3 conditions1 sponsor1 location
NCT04933539
Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
PHASE2Active, not recruiting
14 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2032
1 condition2 sponsors1 location
NCT05502731
Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis
PHASE4Not yet recruiting
40 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05562427
Program for Fully Understanding Eating and Lifestyle Change (FUEL)
NARecruiting
150 participants
Started: Oct 31, 2022 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT05545917
Advanced Practice Physiotherapy Care in Emergency Departments
NANot yet recruiting
744 participants
Started: Oct 31, 2022 · Completed: Mar 31, 2026
3 conditions2 sponsors0 locations
NCT05127161
Broad Implementation of Outpatient Stewardship
NAActive, not recruiting
1,032 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
4 conditions8 sponsors5 locations
NCT05437263
A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis
PHASE3Active, not recruiting
241 participants
Started: Oct 31, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor109 locations
NCT04624555
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
N/ARecruiting
50 participants
Started: Oct 31, 2022 · Completed: Jan 30, 2026
5 conditions1 sponsor1 location
NCT05325281
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
PHASE1Active, not recruiting
8 participants
Started: Oct 31, 2022 · Completed: Sep 30, 2025
1 condition3 sponsors1 location
NCT05525715
A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis
PHASE1/PHASE2Not yet recruiting
260 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations